Vi-Jon, Inc. recalls Topical Solution USP Hydrogen Peroxide First Aid Antiseptic Oral Debriding…
Oz. (1 QT) 946 mL bottle, Distributed By: Discount Drug Mart 2… beginning February 20, 2019, in a drug recall whose distribution included Ohio.
Vi-Jon, Inc. began a drug recall on February 20, 2019 whose reported distribution included Ohio. FDA
What the record shows
recalled Topical Solution USP Hydrogen Peroxide First Aid Antiseptic Oral Debriding Agent 32 Fl. Oz. (1 QT) 946 mL bottle, Distributed By: Discount Drug Mart 2… beginning February 20, 2019, in a drug recall whose distribution included Ohio. The stated reason: Cross Contamination: Presence of IPA in finished product. FDA graded it Class II — use may cause temporary or medically reversible health consequences. Quantity affected: 6756 32 oz bottles. The recall is listed as terminated. FDA
Context
By the numbers
- Date of record: February 20, 2019 FDA
- Recall number: D-0520-2019 FDA
- Recalls in this action: 1 FDA
- Recalling firm: Vi-Jon, Inc. FDA
- Product: Topical Solution USP Hydrogen Peroxide First Aid Antiseptic Oral Debriding Agent 32 Fl. Oz. (1 QT) 946 mL bottle… FDA
- Reason for recall: Cross Contamination: Presence of IPA in finished product. FDA
Assembled mechanically from the source filing and The Lantern's own record database — no AI-written prose. Every figure above appears verbatim in the cited record, which is linked on this page. FDA
Sources
The source filing
| Recall number | D-0520-2019 |
|---|---|
| Recalls in this action | 1 |
| Recalling firm | Vi-Jon, Inc. |
| Product | Topical Solution USP Hydrogen Peroxide First Aid Antiseptic Oral Debriding Agent 32 Fl. Oz. (1 QT) 946 mL bottle, Distributed By: Discount Drug Mart 211 Commerce Drive, Medina, Ohio 44256 NDC 53943-871-45 UPC 0-93351-12758-8 |
| Reason for recall | Cross Contamination: Presence of IPA in finished product. |
| Classification | Class II — use may cause temporary or medically reversible health consequences |
| Recall type | drug |
| Quantity | 6756 32 oz bottles |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm initiated |
| Initiated | 20190220 |
| Reported | 20190313 |
| Distribution | Distributed in Ohio |
| Firm location | Smyrna, TN, United States |
Published by U.S. Food and Drug Administration (openFDA). This is the agency's public filing as The Lantern received it, shown with its fields named in plain English.